← Back to Search

Behavioural Intervention

Digital Sleep Programs for Preventing Perinatal Depression (PRISM Trial)

N/A
Recruiting
Led By Jennifer N Felder, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 months postpartum
Awards & highlights
No Placebo-Only Group

Summary

This trial compares two online sleep programs for pregnant people with insomnia to see if they can prevent depression. One program focuses on changing thoughts and behaviors about sleep, while the other teaches good sleep habits. The program that changes thoughts and behaviors has been shown to be effective in various populations, including shift workers, menopausal women, and cancer survivors.

Who is the study for?
This trial is for pregnant individuals between 14-28 weeks gestation, aged 18 or older, who have insomnia and access to the internet. They must speak English but can't join if they work night shifts, have other sleep disorders or severe psychiatric conditions like bipolar disorder or active suicidality, are currently majorly depressed, or take antidepressants.
What is being tested?
The study compares two digital programs for improving sleep in pregnant people with insomnia: cognitive behavioral therapy (CBT-I) and sleep hygiene education (SHE). Each participant will follow one of these six-week online courses to see which is better at preventing depression during and after pregnancy.
What are the potential side effects?
Since both interventions are non-pharmacological and involve only educational content delivered digitally, there are no direct physical side effects expected from participating in this trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 months postpartum
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 months postpartum for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Incidence of perinatal depression, as assessed by the Structured Clinical Interview for the DSM-5 (SCID)
Secondary study objectives
Depressive Symptoms
Baseline depressive symptom severity as a moderator, as assessed by the PHQ-9
Anxiety
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Digital cognitive behavior therapy for insomnia (CBT-I)Experimental Treatment1 Intervention
Group II: Digital sleep hygiene education (SHE)Active Control1 Intervention

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for insomnia include Cognitive Behavioral Therapy for Insomnia (CBT-I), which focuses on behavioral modification to improve sleep patterns and reduce insomnia symptoms. CBT-I works by addressing maladaptive thoughts and behaviors that contribute to insomnia, such as poor sleep hygiene, irregular sleep schedules, and anxiety about sleep. Techniques used in CBT-I include stimulus control, sleep restriction, cognitive restructuring, and relaxation training. These interventions help patients develop healthier sleep habits, reduce sleep-related anxiety, and improve overall sleep quality. This matters for insomnia patients as it provides a non-pharmacological, sustainable approach to managing and potentially resolving their sleep issues.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,587 Previous Clinical Trials
14,900,678 Total Patients Enrolled
73 Trials studying Depression
26,125 Patients Enrolled for Depression
Stanford UniversityOTHER
2,474 Previous Clinical Trials
17,501,442 Total Patients Enrolled
108 Trials studying Depression
93,368 Patients Enrolled for Depression
Jennifer N Felder, PhDPrincipal InvestigatorUniversity of California, San Francisco
2 Previous Clinical Trials
260 Total Patients Enrolled

Media Library

Digital CBT-I (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05596318 — N/A
Depression Research Study Groups: Digital cognitive behavior therapy for insomnia (CBT-I), Digital sleep hygiene education (SHE)
Depression Clinical Trial 2023: Digital CBT-I Highlights & Side Effects. Trial Name: NCT05596318 — N/A
Digital CBT-I (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05596318 — N/A
~268 spots leftby Apr 2027